Katel Aubert-Herve - Publications

Recent advances in nanomaterial delivery systems to administer metformin for cancer therapy.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: March 05, 2026

Development of anti-EGFR targeted magnetic nanoparticles for doxorubicin delivery into triple negative breast cancer cells.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: June 19, 2025

Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer.

Journal: Nanoscale

Published: January 08, 2025

Design, optimization, characterization, and in vitro evaluation of metformin-loaded liposomes for triple negative breast cancer treatment.

Journal: Journal of liposome research

Published: March 09, 2024

In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model.

Journal: International journal of pharmaceutics: X

Published: November 24, 2022

Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines.

Journal: Pharmaceutics

Published: October 20, 2022

Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells.

Journal: Pharmaceutics

Published: October 15, 2022

Formation of miRNA Nanoprobes-Conjugation Approaches Leading to the Functionalization.

Journal: Molecules (Basel, Switzerland)

Published: September 27, 2022

Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin.

Journal: Pharmaceutics

Published: June 28, 2022

Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies.

Journal: Pharmaceutics

Published: April 27, 2022

WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model.

Journal: International journal of pharmaceutics

Published: March 02, 2022

Two-step formulation of magnetic nanoprobes for microRNA capture.

Journal: RSC advances

Published: December 13, 2021